WHITE PAPER

Hi-Definition Phenotyping™

Achieve your regulatory milestone faster with better decision-making and less re-work.

Harness the full power of metabolomics for your biomarker-driven drug development with the industry’s broadest and most precise metabolite discovery platform.

Inform

Inform adaptive trial design strategies and responses in real-time.

Monitor

Dynamically monitor and optimize dose-response by tracking prodromal signals of efficacy and safety.

g

Optimize

Optimize eligibility criteria by proactively identifying responder/non-responder baseline characteristics.

Z

Quality

Maintain trial quality by monitoring patient compliance, subject outliers and potential drug-drug interactions.

Post-Market

Strengthen post-market surveillance with a differentiated drug profile and competitor analysis.

Biomarkers

Increase drug development success rate and accelerate the availability of new therapeutics.

GET THE WHITE PAPER